"The model had 92% sensitivity and 92% specificity. We obtained similar results in the independent validation cohort. AIB1 and EIF5A2 show promise for the noninvasive detection of bladder cancer. The model based on AIB1 EIF5A2 and NMP22 outperformed each of the three individual biomarkers for detecting Bladder cancer."xsd:string